Cargando…

Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test

BACKGROUND: We evaluated the performance of primary high-risk human papillomavirus (hrHPV) testing by hybrid capture 2 (HC2) with different thresholds for positivity, in comparison with conventional cytology. METHODS: We used data of 25 871 women (aged 30–60 years) from the intervention group of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rijkaart, D C, Coupe, V M H, van Kemenade, F J, Heideman, D A M, Hesselink, A T, Verweij, W, Rozendaal, L, Verheijen, R H, Snijders, P J, Berkhof, J, Meijer, C J L M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965874/ https://www.ncbi.nlm.nih.gov/pubmed/20808310 http://dx.doi.org/10.1038/sj.bjc.6605869

Ejemplares similares

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications
por: Rijkaart, D C, et al.
Publicado: (2012)

Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study
por: Uijterwaal, M H, et al.
Publicado: (2014)

Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases
por: Gök, M, et al.
Publicado: (2011)

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
por: Bulk, S, et al.
Publicado: (2006)

Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing
por: Kocken, M, et al.
Publicado: (2012)

HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test
por: Polman, Nicole J, et al.
Publicado: (2017)

HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study
por: Gök, Murat, et al.
Publicado: (2010)

Risk of cervical precancer among HPV–negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a randomized screening study
por: Inturrisi, Federica, et al.
Publicado: (2022)

High-risk HPV type-specific clearance rates in cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2007)

The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency
por: Bulk, S, et al.
Publicado: (2007)

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening
por: Coupé, V M H, et al.
Publicado: (2008)

Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2005)

HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears
por: Zielinski, G D, et al.
Publicado: (2001)

Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women
por: De Strooper, Lise M.A., et al.
Publicado: (2016)

Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia
por: Nobbenhuis, M A E, et al.
Publicado: (2001)

Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up
por: De Strooper, Lise M.A., et al.
Publicado: (2018)

Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area
por: Bulk, S, et al.
Publicado: (2003)

Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping
por: Dick, Stèfanie, et al.
Publicado: (2021)

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women
por: Luttmer, Roosmarijn, et al.
Publicado: (2016)

Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer ≥15 years later
por: Inturrisi, Federica, et al.
Publicado: (2022)

A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears
por: Jacobs, M V, et al.
Publicado: (2000)

Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape
por: Snellenberg, Suzanne, et al.
Publicado: (2012)

Extended duration of the detectable stage by adding HPV test in cervical cancer screening
por: van den Akker-van Marie, M E, et al.
Publicado: (2003)

Cervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 Tests
por: Tardif, Keith D., et al.
Publicado: (2016)

Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands
por: Schurink‐van ’t Klooster, Tessa M., et al.
Publicado: (2023)

Performance of cytology and human papillomavirus testing in relation to the menstrual cycle
por: Sherman, M E, et al.
Publicado: (2006)

Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II(+) detection rates
por: Rozemeijer, Kirsten, et al.
Publicado: (2015)

Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV‐positive women: Results from a Dutch primary HPV‐based screening cohort
por: Verhoef, Lisanne, et al.
Publicado: (2021)

Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study
por: Inturrisi, Federica, et al.
Publicado: (2021)

Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study
por: van Lanschot, Meta C. J., et al.
Publicado: (2017)

Influence of experimental protocol on response rate and repeatability of mechanical threshold testing in dogs
por: Harris, L.K., et al.
Publicado: (2015)

Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening
por: Verhoef, Lisanne, et al.
Publicado: (2023)

Defibrillation threshold testing: What is all that noise?
por: Oomen, Ad W.G.J., et al.
Publicado: (2019)

Evaluation of cytology versus human papillomavirus-based cervical cancer screening algorithms in Bhutan
por: Tshomo, Ugyen, et al.
Publicado: (2017)

Error Rates in Cervical Cytological Screening Tests
por: May, D.
Publicado: (1974)

HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study
por: Kelly, R S, et al.
Publicado: (2011)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
por: Wisse, P. H. A., et al.
Publicado: (2022)

Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel
por: Polman, N. J., et al.
Publicado: (2017)

Granular Quality Reporting for Cervical Cytology Testing
por: Wagholikar, Kavishwar B., et al.
Publicado: (2015)

Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study
por: Mesher, D, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_93qdu805qf0t223939n179eaeu